Tuesday, January 31, 2012

Pfizer Recalls 1 Million Birth-Control Packs (Lo/Ovral) on Dose Mix-Up

Pfizer Inc., the world’s biggest drugmaker, recalled 1 million packs of birth-control pills after discovering a packaging error that may cause women to take the wrong dosages and put them at risk for unintended pregnancies.

The company recalled 14 lots of Lo/Ovral-28 tablets and 14 lots of a generic version of the medicine, New York-based Pfizer said today in an e-mail. About 1 million packs of 28 tablets were withdrawn, Grace Ann Arnold, a Pfizer spokeswoman, said in a separate e-mail.

The tablets, manufactured and packaged by Pfizer, were marketed by closely held Akrimax Rx Products of Cranford, New Jersey under the Akrimax Pharmaceuticals brand.

Each pack contains 21 white tablets that contain the synthetic hormones norgestrel and ethinyl estradiol and are taken for 21 consecutive days. The remaining seven tablets are inactive pink pills taken for a week.
“An investigation by Pfizer found that some blister packs may contain an inexact count of inert or active ingredient- tablets and that the tablets may be out of sequence,” the company said. That could cause women to take an incorrect daily dosage and increase the risk of accidental pregnancy.

Enhanced by Zemanta